Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
DDX3 modulates the tumor microenvironment via its role in endoplasmic reticulum-associated translation
Hung-Hsi Chen1, Hsin-I Yu1, Rudy Rudy1
1Institute of Biomedical Sciences, Academia Sinica, 128 Academy Road Section 2, Nankang, Taipei 11529, Taiwan.
Abstract:
Using antibody arrays, we found that the RNA helicase DDX3 modulates the expression of secreted signaling factors in oral squamous cell carcinoma (OSCC) cells. Ribo-seq analysis confirmed amphiregulin (AREG) as a translational target of DDX3. AREG exerts important biological functions in cancer, including promoting cell migration and paracrine effects of OSCC cells and reprogramming the tumor microenvironment (TME) of OSCC in mice. DDX3-mediated translational control of AREG involves its 3'-untranslated region. Proteomics identified the signal recognition particle (SRP) as an unprecedented interacting partner of DDX3. DDX3 and SRP54 were located near the endoplasmic reticulum, regulated the expression of a common set of secreted factors, and were essential for targeting AREG mRNA to membrane-bound polyribosomes. Finally, OSCC-associated mutant DDX3 increased the expression of AREG, emphasizing the role of DDX3 in tumor progression via SRP-dependent, endoplasmic reticulum-associated translation. Therefore, pharmacological targeting of DDX3 may inhibit the tumor-promoting functions of the TME.
Insights
The RNA helicase DDX3 protein targets amphiregulin (AREG) mRNA for translation, influencing oral cancer progression and the tumor microenvironment (TME). Targeting DDX3 may offer a therapeutic strategy against oral squamous cell carcinoma (OSCC).
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Oral squamous cell carcinoma (OSCC) is a significant global health concern.
- The tumor microenvironment (TME) plays a critical role in OSCC progression.
- RNA helicase DDX3 is implicated in various cellular processes, including cancer.
Purpose of the Study:
- To investigate the role of RNA helicase DDX3 in regulating secreted signaling factors in OSCC.
- To identify translational targets of DDX3 in OSCC.
- To elucidate the mechanism by which DDX3 influences the TME in OSCC.
Main Methods:
- Antibody arrays to profile secreted factors.
- Ribo-seq to identify translational targets.
- Proteomics to identify interacting partners.
- Immunofluorescence to determine subcellular localization.
Main Results:
- DDX3 modulates secreted signaling factors in OSCC cells, with amphiregulin (AREG) identified as a translational target.
- DDX3 regulates AREG translation via its 3'-untranslated region.
- DDX3 interacts with the signal recognition particle (SRP) and co-localizes with SRP54 near the endoplasmic reticulum.
- DDX3 and SRP54 are essential for targeting AREG mRNA to membrane-bound polyribosomes, influencing TME reprogramming.
- OSCC-associated mutant DDX3 enhances AREG expression, highlighting its role in tumor progression.
Conclusions:
- DDX3 controls AREG translation through an SRP-dependent, ER-associated mechanism, impacting OSCC progression and TME.
- Targeting DDX3 may represent a novel therapeutic strategy to inhibit tumor-promoting functions in the OSCC TME.
Related Concept Videos
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
The Tumor Microenvironment
Regulated mRNA Transport
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of the Unfolded Protein Response

